insights.pfizer.comHome - Pfizer Investor Insights

Pfizer Inc Stories & News Materials Facebook Linkedin Stay Informed Pfizer Reports First-Quarter 2024 Results Learn More Pfizer Reports Solid First-Quarter 2024 Financial Results Pfizer reported its results for the first quarter of 2024. Read more We Invest in Changing Lives Welcome to our shareholder community. Here you will find updates on our innovation pipeline progress, performance results, and corporate milestones. You’ll also have the opportunity to hear from our management team. Sign up now for Pfizer Investor Insights to receive information about the company and your investment. Pfizer Invests $43 Billion to Battle Cancer Pfizer continues to invest significant capital in the next generation of potential cancer breakthroughs, having announced its proposed acquisition of Seagen, a global biotechnology company that discovers, develops and commercializes transformative cancer medicines. Read more Investors, Submit Your Question to Pfizer We want to hear from you to help ensure that we are providing content that is informative and relevant. Submit a question here about Pfizer’s R&D pipeline, Pfizer’s capital allocation objectives, or Pfizer’s roadmap for the future. In the coming weeks and months, we’ll compile answers to common questions, giving you a way to hear from management on topics of interest to you. Pfizer continues to advance groundbreaking work across all our therapeutics areas while delivering strong results in our innovative R&D pipeline and returning value to shareholders through dividends. Albert Bourla Chairman and CEO Current Stock Price Day High 52 Wk High Day Low 52 Wk Low Stories & News Take a closer look at how our leadership in biopharma is driving innovation, changing patients’ lives and delivering strong returns for shareholders. Explore the latest Pfizer Reports Solid First-Quarter 2024 Financial Results Quiz: Did You Review Pfizer’s 2023 Impact Report? Pfizer’s Journey Towards a Better Tomorrow: 2023 Impact Report Materials Essential Facts and Figures for Shareholders Get access to our latest financial information, strategy and presentations. Explore Join Pfizer Investor Insights Sign up to receive important updates about Pfizer, how we’re innovating for patients and delivering value for shareholders. Email updates will also provide exciting opportunities for individual shareholders to hear from our leadership and experts. I would like to receive information, updates, and hear from leadership regarding Pfizer Investor Insights and other investor relations initiatives in accordance with Pfizer’s Privacy Policy . First name Last name Email (required) (Required) Subscribe Pfizer Inc Facebook Linkedin Contact Us Terms of Use Privacy Policy Forward-looking statements included herein are subject to substantial risks and uncertainties that could cause actual results to differ materially from those expressed or implied by such statements. We encourage you to read our reports filed with the U.S. Securities and Exchange Commission (SEC), including the sections captioned Risk Factors” and Forward Looking Information and Factors that May Affect Future Results,” for a description of such substantial risks and uncertainties. These reports are available at pfizer.com and the SEC’s website . Copyright © 2002 – 2024 Pfizer Investor Insights All rights reserved. This information—including product information—is intended only for residents of the United States. The products discussed herein may have different labeling in different countries. This website contains certain information about Pfizer, but may not contain all information that is material to Pfizer. Join Pfizer Investor Insights I would like to receive information, updates, and hear from leadership regarding Pfizer Investor Insights and other investor relations initiatives in accordance with Pfizer’s Privacy Policy . First name Last name Email (required) (Required) Subscribe...